Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone Low-Dose - High-Dose Study Study

ClinicalTrials.gov ID: NCT01821378

Public ClinicalTrials.gov record NCT01821378. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Low-dose Lurasidone in Acutely Psychotic Subjects With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.

Study identification

NCT ID
NCT01821378
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
412 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2013 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Jul 21, 2016

2013 – 2014

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Woodland International Research Group, Inc. Little Rock Arkansas 72211 —
Comprehensive Clinical Development Cerritos California 90703 —
Synergy Clinical Research of Escondido Escondido California 92025 —
Apostle Clinical Trials, Inc. Long Beach California 90813 —
Cnri, Llc Los Angeles California 90660 —
Pasadena Research Institute Pasadena California 91106 —
Cnri, Llc San Diego California 92102 —
University of California San Diego Medical Center San Diego California 92103 —
Collaborative Neuroscience Network, Inc. Torrance California 90502 —
Western Affiliated Research Institute Denver Colorado 80209 —
Florida Clinical Research Center, LLC - PARENT Maitland Florida 32751 —
University of Miami Medical Center Miami Florida 33136 —
Florida Clinical Research Center, LLC Orlando Florida 32810 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
iResearch Atlanta, LLC Decatur Georgia 30030 —
Via Christi Research, a division of Via Christi Hospitals Wichita, Inc. Wichita Kansas 67214 —
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629 —
Center for Behavioral Health, LLC Rockville Maryland 20850 —
St. Charles Psychiatric Associates Saint Charles Missouri 63301 —
Midwest Research Group Saint Charles Missouri 63304 —
Neurobehavioral Research, Inc. Cedarhurst New York 11516 —
Comprehensive Clinical Development- Holliswood Hospital Holliswood New York 11423 —
Midwest Clinical Research Center, LLC Dayton Ohio 45417 —
CRILifetree Philadelphia Pennsylvania 19139 —
FutureSearch Clinical Trials, L.P. Austin Texas 78731 —
FutureSearch Trials of Dallas, LP Dallas Texas 75231 —
Pillar Clinical Research, LLC Dallas Texas 75243 —
Bayou Clinical Research, Ltd. Houston Texas 77007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01821378, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01821378 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →